BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©The Author(s) 2026.
World J Hepatol. Jan 27, 2026; 18(1): 113753
Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.113753
Figure 1
Figure 1 Flowchart representing patient evaluation and characterization in this retrospective cohort study. 1Standard eligibility criteria are body mass index > 40 kg/m2 or > 35 kg/m2 plus obesity-associated comorbidity. MASLD: Metabolic dysfunction-associated steatotic liver disease; BSE: Bariatric surgery eligible; BSNE: Bariatric surgery non-eligible; RYGB: Roux-en-Y gastric bypass; SG: Sleeve gastrectomy; MBSAQIP: Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program.


Write to the Help Desk